Pursuant to Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018, Sharon Bio Medicine has informed that it enclosed Confirmation Certificate dated January 6, 2023 received from Link Intime India, the Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.